Data / Research funding / Digestive Diseases - (Peptic Ulcer)
Digestive Diseases - (Peptic Ulcer): 36 NIH awards ($37.1M) to 24 organizations
36 NIH awards ($37.1M) in the NIH spending category Digestive Diseases - (Peptic Ulcer), to 24 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
36 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Type IV Protein Secretion in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,592,685 | February 18, 2016 | March 31, 2027 | COVER, TIMOTHY L | reporter.nih.gov |
| Role of the p53 P47S mutation in influencing prevalence and immune response to H. pylori | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,013,399 | January 20, 2021 | December 31, 2026 | CLAIBORNE, DANIEL THOMAS | reporter.nih.gov |
| Targeting NuoD for the treatment of H. pylori | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,555,440 | May 1, 2023 | April 30, 2028 | LEE, RICHARD E. | reporter.nih.gov |
| The function of chemotactic signal transduction during colonization and disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,366,210 | December 1, 2015 | August 31, 2027 | OTTEMANN, KAREN M | reporter.nih.gov |
| Understanding redox-regulated mechanisms of environmental adaptation in gastrointestinal symbionts | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,272,455 | August 1, 2020 | May 31, 2030 | HATZIOS, STAVROULA | reporter.nih.gov |
| Mechanisms and consequence of helical shape generation in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,129,854 | June 1, 2018 | February 28, 2029 | SALAMA, NINA | reporter.nih.gov |
| Genetic requirements of Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,992,451 | December 1, 2003 | January 31, 2027 | SALAMA, NINA | reporter.nih.gov |
| Understanding and manipulating chronic Helicobacter pylori to enhance treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,977,962 | July 16, 2021 | June 30, 2027 | OTTEMANN, KAREN M | reporter.nih.gov |
| Mechanisms of induction of gastric injury by H. pylori | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,956,698 | May 15, 2021 | April 30, 2027 | MARCUS, ELIZABETH A. | reporter.nih.gov |
| Biophysical determinants of chemotaxis in Helicobacter pylori | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,641,132 | February 1, 2022 | January 31, 2027 | LELE, PUSHKAR PRAKASH | reporter.nih.gov |
| Helicobacter Pylori and Gastrointestinal Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,600,756 | August 1, 2001 | June 30, 2025 | PEEK, RICHARD M. | reporter.nih.gov |
| Helicobacter pylori infection and endothelial dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,309,979 | August 15, 2019 | July 31, 2024 | LIU, ZHENGUO | reporter.nih.gov |
| A tethered capsule endoscopic-endomicroscopic (TEEM) approach for improving upper GI tract diagnosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,197,633 | February 1, 2019 | December 31, 2024 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| Structure and function of Helicobacter pylori VacA | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $944,680 | May 1, 1996 | November 30, 2024 | COVER, TIMOTHY L | reporter.nih.gov |
| Role of cardiolipin in Helicobacter pylori flagellar biogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $906,000 | February 1, 2019 | January 31, 2026 | HOOVER, TIMOTHY RANDALL | reporter.nih.gov |
| Linking defects in DNA polymerase beta to mitochondrial dysfunction and cytosolic nucleic acid sensor in Helicobacter pylori associated inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $843,464 | December 8, 2023 | October 31, 2028 | KIDANE MULAT, DAWIT | reporter.nih.gov |
| New carcinogenic mechanisms of Helicobacter pylori infection | NIH | National Cancer Institute | 2021 to 2025 | $778,445 | August 1, 2010 | April 30, 2030 | ZAIKA, ALEXANDER I. | reporter.nih.gov |
| Genetic requirements of Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $605,148 | December 1, 2003 | March 31, 2022 | SALAMA, NINA | reporter.nih.gov |
| Using Intervention Mapping and the Multiphase Optimization Strategy to develop multilevel interventions to prevent upper GI bleeding | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $583,200 | July 1, 2019 | February 29, 2024 | KURLANDER, JACOB ELI | reporter.nih.gov |
| N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $491,119 | March 4, 2022 | February 28, 2025 | MCCLAIN, MARK S | reporter.nih.gov |
| Inhibition of lipoprotein synthesis in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $481,250 | July 1, 2025 | June 30, 2027 | MCCLAIN, MARK S | reporter.nih.gov |
| Discovery of H. pylori T cell epitopes unique to minority populations that could contribute to increased gastric cancer rates. | NIH | National Cancer Institute | 2021 | $438,168 | May 1, 2021 | April 30, 2024 | SETTLES, ERIK W | reporter.nih.gov |
| Contribution of Helicobacter pylori HomA and HomB to colonization and disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $419,365 | June 21, 2021 | May 31, 2025 | MELTON-CELSA, ANGELA | reporter.nih.gov |
| Defining receptor-ligand interactions in gastric epithelial immunosurveillance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $412,096 | June 23, 2022 | May 31, 2025 | BIMCZOK, DIANE | reporter.nih.gov |
| MDSC Polarization and Helicobacter-induced Gastric Metaplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $409,682 | September 15, 2018 | August 31, 2024 | MERCHANT, JUANITA L. | reporter.nih.gov |
| Deciphering Helicobacter pylori's glycocode: uncovering and harnessing drug targets | NIH | National Institute of General Medical Sciences | 2021 | $400,669 | July 1, 2015 | August 31, 2025 | DUBE, DANIELLE H. | reporter.nih.gov |
| The Helicobacter pylori VacA Receptor Binding Site | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $395,377 | February 7, 2024 | December 31, 2026 | BLANKE, STEVEN R. | reporter.nih.gov |
| Characterization of Bacterial Lectin-Carbohydrate Binding and Development of Anti-Adhesion Inhibitors | NIH | National Institute of General Medical Sciences | 2023 | $377,693 | June 1, 2023 | May 31, 2026 | MCMAHON, CAITLIN M | reporter.nih.gov |
| Ion channels in the tubulovesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $344,265 | December 1, 2017 | November 30, 2024 | HUME, RICHARD IRWIN | reporter.nih.gov |
| Sox4 Dependent Parietal Cell Plasticity in Gastric Ulcer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $251,250 | September 6, 2024 | July 31, 2026 | HUH, WON JAE | reporter.nih.gov |
| Rapid evolution and bacterial evasion by a primate cell adhesion protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $136,192 | August 1, 2020 | July 31, 2023 | BAKER, EMILYCLARE P | reporter.nih.gov |
| Redox Regulation of Host Ribosomal Proteins during Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $97,477 | September 1, 2024 | December 31, 2026 | RAMANATHAN, RENUKA GANESH | reporter.nih.gov |
| How ribosomal silencing promotes chronic infection of the gastric pathogen Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $84,668 | July 29, 2024 | September 28, 2026 | ELSHENAWI, YASMINE | reporter.nih.gov |
| The role of VacA in Helicobacter pylori-host cell cholesterol homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $49,538 | July 1, 2025 | June 30, 2028 | CASO, GEORGIA C | reporter.nih.gov |
| Mechanisms and consequences of cytoskeletal control of Helicobacter pylori cell shape | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $31,902 | August 1, 2020 | March 31, 2022 | SICHEL, SOPHIE R. | reporter.nih.gov |
| Mechanisms and consequence of helical shape generation in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1 | June 1, 2018 | March 31, 2022 | SALAMA, NINA | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 18 | $6,937,398 | 0 | $0 |
| 2024 | 16 | $6,878,717 | 0 | $0 |
| 2023 | 15 | $6,555,925 | 0 | $0 |
| 2022 | 22 | $8,365,022 | 0 | $0 |
| 2021 | 21 | $8,351,241 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 21 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 21 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 21 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.